Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2012-07
Metadata
Show full item recordCitation
Dig Dis Sci 2012, 57(7):1959-64Abstract
Statin drugs are widely used worldwide and are generally considered safe and well tolerated. Only small proportion of patients receiving statins develop elevations of liver enzymes and an even smaller proportion will have clinically significant hepatitis induced by statins. We describe four patients with jaundice caused by drug-induced liver injury, where the most likely agent was a statin drug, over a period of approximately three year in Iceland. We calculate the risk of jaundice caused by statin drugs, from sale in the whole country of Iceland, to be one in 17,434 users a year. This is a higher risk than has previously been estimated and we challenge the current opinion that statins rarely cause clinically significant drug-induced liver injury and encourage alertness when managing patients with statins with regard to clinical signs of hepatitis before jaundice occurs.Additional Links
http://dx.doi.org/10.1007/s10620-011-1950-1Rights
Archived with thanks to Digestive diseases and sciencesae974a485f413a2113503eed53cd6c53
10.1007/s10620-011-1950-1
Scopus Count
Collections
Related articles
- Drug-induced liver injury associated with statins.
- Authors: Russo MW, Scobey M, Bonkovsky HL
- Issue date: 2009 Nov
- Hepatotoxicity of statins and other lipid-lowering agents.
- Authors: Björnsson ES
- Issue date: 2017 Feb
- Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry.
- Authors: Perdices EV, Medina-Cáliz I, Hernando S, Ortega A, Martín-Ocaña F, Navarro JM, Peláez G, Castiella A, Hallal H, Romero-Gómez M, González-Jiménez A, Robles-Díaz M, Lucena MI, Andrade RJ
- Issue date: 2014 Apr
- Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians.
- Authors: Rzouq FS, Volk ML, Hatoum HH, Talluri SK, Mummadi RR, Sood GK
- Issue date: 2010 Aug
- Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
- Authors: Russo MW, Hoofnagle JH, Gu J, Fontana RJ, Barnhart H, Kleiner DE, Chalasani N, Bonkovsky HL
- Issue date: 2014 Aug